NCT00071526

Brief Summary

Several studies have reported that diabetic subjects have lower plasma vitamin C concentrations than non-diabetic subjects. Although urinary vitamin C loss in diabetic subjects was reported to be increased in two studies, these are difficult to interpret due to lack of controlled vitamin C intake, inadequate sampling, lack of control subjects, or methodology uncertainties in vitamin C assay and sample processing. Consequently, it is unclear whether diabetic subjects truly have both low plasma and high urine vitamin C concentrations. We propose that low plasma vitamin C concentrations in diabetic subjects are due in part to inappropriate renal loss of vitamin C in these subjects but not in healthy controls. We will study nondiabetic controls and cohorts with diabetes. Vitamin C concentrations in plasma, RBCs, and urine will be measured in outpatients. In those willing to be admitted to the Clinical Center, we will measure vitamin C pharmacokinetics to determine the relative bioavailability for vitamin C in individuals with and without abnormal urinary loss of vitamin C (or renal leak). Single nucleotide polymorphisms (SNPs) will be determined in genomic DNA responsible for the two proteins mediating sodium dependent vitamin C transport, SVCT1 and SVCT2. We will also explore mechanisms underlying abnormal urinary vitamin C loss.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2003

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 28, 2003

Completed
2.5 years until next milestone

Study Start

First participant enrolled

April 11, 2006

Completed
Last Updated

May 5, 2026

Status Verified

April 28, 2026

First QC Date

October 27, 2003

Last Update Submit

May 2, 2026

Conditions

Keywords

Renal ThresholdDiabetes MellitusProteinuriaPlasma ConcentrationsHealthy Volunteer

Outcome Measures

Primary Outcomes (1)

  • Plasma, neutrophil and RBC Vitamin C concentrates

    Measurements of plasma, neutrophil and red blood cell vitamin c concentrations in diabetic subjects as compared to healthy controls.

    end of study

Secondary Outcomes (2)

  • Urinary vitamin C concentration

    end of study

  • Determine the renal threshold and relative bioavailability for vitamin C

    end of study

Study Arms (3)

Diabetes Type I

Subjects with Type I diabetes mellitus

Diabetes Type II

Subjects with Type II diabetes mellitus

Healthy Volunteers

Healthy Volunteers

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Community sample.

You may qualify if:

  • To be included in the study, study subjects should be:
  • Aged 18-65 years.
  • Either:
  • Have no diagnosis of diabetes: "nondiabetic controls", or
  • Have a diagnosis in their medical history of either Type 1 or Type 2 diabetes

You may not qualify if:

  • Unable or unwilling to provide a signed and dated informed consent form
  • Unable or unwilling to comply with study procedures and lifestyle considerations
  • Study participants interested in participating in Arms 2 and/or 3 will be excluded from this further participation if they meet any of the following:
  • significant organ malfunction leading to clinical instability including liver disease, pulmonary disease, ischemic heart disease, heart failure, stroke, peripheral vascular disease, and anemia at investigator discretion
  • other serious or chronic illness; history of serious or chronic illness; coronary artery disease, or peripheral vascular disease resulting in clinical instability
  • pregnancy or lactation
  • presence of other conditions which, in the judgment of the investigators, can influence vitamin C metabolism or vitamin C renal handling

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

RECRUITING

Related Publications (4)

  • Levine M. New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med. 1986 Apr 3;314(14):892-902. doi: 10.1056/NEJM198604033141407. No abstract available.

    PMID: 3513016BACKGROUND
  • Goodwin JS, Goodwin JM, Garry PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA. 1983 Jun 3;249(21):2917-21.

    PMID: 6842805BACKGROUND
  • Fata FT, Herzlich BC, Schiffman G, Ast AL. Impaired antibody responses to pneumococcal polysaccharide in elderly patients with low serum vitamin B12 levels. Ann Intern Med. 1996 Feb 1;124(3):299-304. doi: 10.7326/0003-4819-124-3-199602010-00003.

    PMID: 8554224BACKGROUND
  • Ebenuwa I, Violet PC, Tu H, Lee C, Munyan N, Wang Y, Niyyati M, Patra K, Wilkins KJ, Parrow N, Levine M. Altered RBC deformability in diabetes: clinical characteristics and RBC pathophysiology. Cardiovasc Diabetol. 2024 Oct 18;23(1):370. doi: 10.1186/s12933-024-02453-2.

Related Links

MeSH Terms

Conditions

Diabetes MellitusProteinuria

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ifechukwude C Ebenuwa, M.D.

    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Razi S Berman, C.R.N.P.

CONTACT

Ifechukwude C Ebenuwa, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2003

First Posted

October 28, 2003

Study Start

April 11, 2006

Last Updated

May 5, 2026

Record last verified: 2026-04-28

Locations